Toxic Epidermal Necrolysis and Stevens - Johnson Syndrome Following Sintilimab Administration in a Non-Small Cell Lung Cancer Patient: A Case Report

Immune checkpoint inhibitors such as monoclonal antibodies have been used recently with greater effect for the management of non-small cell lung cancer (NSCLC). Sintilimab, a fully human IgG4 monoclonal antibody is specific for the immune checkpoint protein programmed cell death receptor-1 (PD-1). I...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Ziyu, Chen, Xiaoli, Sun, Zhaoshen, Shen, Xiaowei, Huang, Yaju, Liu, Jingbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627061/
https://www.ncbi.nlm.nih.gov/pubmed/37936597
http://dx.doi.org/10.2147/JIR.S427336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627061/
https://www.ncbi.nlm.nih.gov/pubmed/37936597
http://dx.doi.org/10.2147/JIR.S427336

Ejemplares similares